Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Apr 6;18(4):e0282423.
doi: 10.1371/journal.pone.0282423. eCollection 2023.

The impact of COVID-19 in children with Sickle Cell Disease: Results of a multicentric registry

Affiliations
Multicenter Study

The impact of COVID-19 in children with Sickle Cell Disease: Results of a multicentric registry

Claudia de Melo Oliveira et al. PLoS One. .

Abstract

Objective: To analyze the outcomes of children with sickle cell disease (SCD) and COVID-19.

Method: A multicenter prospective study was conducted in five hematological centers from Central and Southeast Brazil, starting in April 2020. The variables recorded include clinical symptoms, diagnostic methods, therapeutic measures, and treatment sites. The clinical repercussions of the infection on the initial treatment and the overall prognosis were also evaluated.

Results: Twenty-five unvaccinated children, aged 4 to 17 years, with SCD and a positive SARS-CoV-2 RT-PCR result participated in this study. Patients were classified as SCD types SS (n = 20, 80%) and SC (n = 5, 20%). Clinical characteristics and evolution were similar in both groups (p>0.05), except for the fetal hemoglobin value which was higher among the SC patients (p = 0.025). The most frequent symptoms were hyperthermia (72%) and cough (40%). Three children were admitted to the intensive care unit, all of whom were overweight/obese (p = 0.078). No deaths were observed.

Conclusions: Although SCD leads to specific complications, the results found in this sample suggest that COVID-19 does not seem to carry an increased mortality risk in pediatric patients with this disease.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Rosenfeld LG, Bacal NS, Cuder MAM, Silva AG da, Machado ÍE, Pereira CA, et al.. Prevalence of hemoglobinopathies in the Brazilian adult population: National Health Survey 2014–2015. Revista Brasileira de Epidemiologia [Internet]. 2019;22(2). Available from: https://www.scielo.br/scielo.php?pid=S1415-790X2019000300411&script=sci_.... - PubMed
    1. Ministério da Saúde. Relatório anual de dados do PNTN, 2014 a 2018. Brasília: Ministério da Saúde; Avaiable from: https://www.camara.leg.br/proposicoesWeb/prop_mostrarintegra;jsessionid=....
    1. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of Sickle Cell Disease. Annual Review of Pathology: Mechanisms of Disease. 2019. Jan 24;14(1):263–92. doi: 10.1146/annurev-pathmechdis-012418-012838 - DOI - PMC - PubMed
    1. Inusa B, Hsu L, Kohli N, Patel A, Ominu-Evbota K, Anie K, et al.. Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment. International Journal of Neonatal Screening [Internet]. 2019. May 7;5(2):20. Available from: https://www.mdpi.com/2409-515X/5/2/20. doi: 10.3390/ijns5020020 - DOI - PMC - PubMed
    1. Miller AC, Subramanian RA, Safi F, Sinert R, Zehtabchi S, Elamin EM. Influenza A 2009 (H1N1) Virus in Admitted and Critically Ill Patients. Journal of Intensive Care Medicine. 2011. Feb 7;27(1):25–31. doi: 10.1177/0885066610393626 - DOI - PubMed

Publication types